Market Herald logo

Subscribe

Be the first with the news that moves the market
  • AI/ML Innovations (AIML) subsidiary Tech2Heal is launching an independent clinical study to evaluate the effectiveness of Qookka, a depression and anxiety therapy platform
  • AI/ML is a business operating in the fields of artificial intelligence and machine learning
  • The study is being conducted in partnership with a public hospital and research laboratory in Paris, France
  • The goal for this study is to gain “Class IIa” approvals and certification for Qookka as a medical device
  • AI/ML Innovations Inc. (AIML) is up 6.45 per cent and is trading at $0.16 per share as of 2:22 p.m. ET

AI/ML Innovations (AIML) subsidiary Tech2Heal is launching an independent clinical study to evaluate the effectiveness of Qookka, a depression and anxiety therapy platform.

AI/ML is a business operating in the growing fields of artificial intelligence and machine learning.

The study is being conducted in partnership with a public hospital and research laboratory in Paris, France.

The company’s goal for this study is to gain “Class IIa” approvals and certification from European health authorities for Qookka as a medical device.

AI/ML described Qookka as a digital therapy solution for anxious and depressed patients. Qookka is based on acceptance and commitment therapy paired with personalized therapy modules for patients and their families and a remote monitoring system for a patient’s progress.

“In addition to Tech2Heal’s plans for Qookka to be recognized as a medical device in Europe, we are also looking forward to the possibility of deploying the technology in the North American marketplace through AI/ML’s majority-owned subsidiary, AI Rx Inc., which owns the distribution rights to this exciting technology in the US and Canada,” said Tim Daniels, Chairman of AI/ML, said.

AI/ML Innovations Inc. (AIML) is up 6.45 per cent and is trading at $0.16 per share as of 2:22 p.m. ET.

More From The Market Herald
Small Pharma - CEO, George Tziras.

" Small Pharma (TSXV:DMT) announces NCIB

Small Pharma (DMT) has received TSXV approval for a normal course issuer bid.

" GameSquare’s (CSE:GSQ) Fourth Frame Studios to be represented by UTA

GameSquare Esports (GSQ) announced that United Talent Agency (UTA) will represent Fourth Frame Studios, a GameSquare Esports company.

" Sixth Wave (CSE:SIXW) announce addition to Board of Directors

Sixth Wave (SIXW) has appointed Patricia Steadman to the Board of Directors effective immediately.

" Absolute Software (TSX:ABST) bolsters Secure Endpoint portfolio

Absolute Software (ABST) has introduced enhancements to its Secure Endpoint portfolio with new resilience and intelligence capabilities.